Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
8 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
On Thursday, Ligand Pharmaceuticals (NASDAQ: LGND ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Full Transcri
The EPCORE DLBCL-2 trial showed that epcoritamab combined with R-CHOP reduced the risk of disease progression or death by 51% compared to R-CHOP alone in newly diagnosed diffuse large B-cell lymphoma patients.
Oscar Health (NYSE: OSCR ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Oscar Health report
Amylyx Pharma (NASDAQ: AMLX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Amylyx Pharma re
For best results when printing this announcement, please click on link below: Samsung Introduces Galaxy Tab S12 Series: The Ultimate Productivity Powerhouse Built for Growth Packed into a remarkably slim, functional design with sustained intuitive performance, long-lasting battery life and the latest Galaxy AI, the Gal
On Wednesday, GRAIL (NASDAQ: GRAL ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary GRAIL reported a strong second quarter 2026
The company said second-quarter revenue rose 30.1% year over year to 1.39 billion RMB, while net income increased 35.6% to 413.2 million RMB. Yuanbao also said cash reserves totaled 5.16 billion RMB and it had repurchased about 114,000 ADS for US$1.6 million as of Aug. 31, 2026.
WORK Medical Technology Group submits filing to SEC, disclosure details unknown